113 related articles for article (PubMed ID: 6321174)
21. Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor.
Heath JK; Gowen M; Meikle MC; Reynolds JJ
J Periodontal Res; 1982 Mar; 17(2):183-90. PubMed ID: 6284907
[No Abstract] [Full Text] [Related]
22. Characterization of the metalloproteinase inhibitor produced by bovine articular chondrocyte cultures.
Morales TI; Kuettner KE; Howell DS; Woessner JF
Biochim Biophys Acta; 1983 Oct; 760(2):221-9. PubMed ID: 6313063
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone regulation of matrix degrading enzymes in rat osteoblastic osteosarcoma 17/2.8 cells.
Vernillo AT; Ramamurthy NS; Lee HM; Rifkin BR
Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):323-39. PubMed ID: 1324516
[TBL] [Abstract][Full Text] [Related]
24. Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases.
Dean DD; Woessner JF
Biochem J; 1984 Feb; 218(1):277-80. PubMed ID: 6370238
[TBL] [Abstract][Full Text] [Related]
25. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
Ward RV; Hembry RM; Reynolds JJ; Murphy G
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
27. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
28. Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture.
Murphy G; McGuire MB; Russell RG; Reynolds JJ
Clin Sci (Lond); 1981 Dec; 61(6):711-6. PubMed ID: 6271450
[TBL] [Abstract][Full Text] [Related]
29. The enzymatic evaluation of procollagenase and collagenase inhibitors in crude biological media.
Lefebvre V; Vaes G
Biochim Biophys Acta; 1989 Sep; 992(3):355-61. PubMed ID: 2550082
[TBL] [Abstract][Full Text] [Related]
30. Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries.
Curry TE; Mann JS; Estes RS; Jones PB
Endocrinology; 1990 Jul; 127(1):63-8. PubMed ID: 1694500
[TBL] [Abstract][Full Text] [Related]
31. Gelatinase and proteoglycanase activity during the periovulatory period in the rat.
Curry TE; Mann JS; Huang MH; Keeble SC
Biol Reprod; 1992 Feb; 46(2):256-64. PubMed ID: 1311210
[TBL] [Abstract][Full Text] [Related]
32. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
Murphy G; Ward R; Hembry RM; Reynolds JJ; Kühn K; Tryggvason K
Biochem J; 1989 Mar; 258(2):463-72. PubMed ID: 2539808
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells.
De Clerck YA; Yean TD; Ratzkin BJ; Lu HS; Langley KE
J Biol Chem; 1989 Oct; 264(29):17445-53. PubMed ID: 2551903
[TBL] [Abstract][Full Text] [Related]
34. Purification and partial amino acid sequence of a bovine cartilage-derived collagenase inhibitor.
Murray JB; Allison K; Sudhalter J; Langer R
J Biol Chem; 1986 Mar; 261(9):4154-9. PubMed ID: 3005321
[TBL] [Abstract][Full Text] [Related]
35. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
Lefebvre V; Peeters-Joris C; Vaes G
Biochim Biophys Acta; 1991 Aug; 1094(1):8-18. PubMed ID: 1653026
[TBL] [Abstract][Full Text] [Related]
36. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components.
Galloway WA; Murphy G; Sandy JD; Gavrilovic J; Cawston TE; Reynolds JJ
Biochem J; 1983 Mar; 209(3):741-52. PubMed ID: 6347180
[TBL] [Abstract][Full Text] [Related]
39. The effects of razoxane (ICRF 159) on the production of collagenase and inhibitor (TIMP) by stimulated rabbit articular chondrocytes.
Duncan SJ; Reynolds JJ
Biochem Pharmacol; 1983 Dec; 32(24):3853-8. PubMed ID: 6318774
[TBL] [Abstract][Full Text] [Related]
40. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
